Pharmaceutical Dosages Delivery System
First Claim
Patent Images
1. A pharmaceutical delivery system for tracking delivery parameters, the system comprising:
- a carrier housing having a closed end and an open end, wherein the carrier housing defines a cavity;
a pharmaceutical agent positioned within the cavity of the carrier housing; and
a cap comprising a top end and a bottom end, wherein the bottom end includes a sealing portion that is in physical communication with the open end of the carrier housing to seal the cavity containing the pharmaceutical agent; and
a device associated with the system, wherein the device produces an identifiable current signature for communicating information.
2 Assignments
0 Petitions
Accused Products
Abstract
Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials.
-
Citations
25 Claims
-
1. A pharmaceutical delivery system for tracking delivery parameters, the system comprising:
-
a carrier housing having a closed end and an open end, wherein the carrier housing defines a cavity; a pharmaceutical agent positioned within the cavity of the carrier housing; and a cap comprising a top end and a bottom end, wherein the bottom end includes a sealing portion that is in physical communication with the open end of the carrier housing to seal the cavity containing the pharmaceutical agent; and a device associated with the system, wherein the device produces an identifiable current signature for communicating information. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A pharmaceutical carrier comprising:
-
a housing that defines a cavity, wherein the housing includes an open end and a closed end; an apparatus positioned within the cavity of the housing for altering the buoyancy of the carrier; a cap comprising a top end and a bottom end, wherein the bottom end defines at least one channel for fitting the cap into the open end of the housing to seal the content of the cavity; and a current control device secured to the cap and for producing a unique current signature, wherein the current control device comprises; a conductance control module secured within a frame for producing an identifiable current signature; and a partial power source comprising a first material and a second material insulated from one another and each of the first material and the second material electrically coupled to the conductance control module, wherein the first material and the second material are secured to the frame. - View Dependent Claims (8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. An ingestible carrier for providing information associated with the ingestion of a pharmaceutical product, the carrier comprising:
-
a dissolvable casing that defines a cavity, wherein the casing includes an open end and a closed end and the pharmaceutical product is positionable within the cavity defined by the casing; a cap comprising a top end and a bottom end that includes a securing portion, wherein the securing portion defines a plurality of channels that allow for insertion of the cap into the open end of the casing; and a current signature-production device associated with the carrier for producing a current signature that represents the information associated with the ingestion of the pharmaceutical product, wherein the device comprises; a frame; a conductance control module secured to the frame for producing the current signature representing the information; and a partial power source comprising a first material and a second material each electrically coupled to the conductance control module, wherein the first material and the second material are secured to the frame and separated by a non-conducting material and wherein the partial power source produces a voltage potential when the first material and the second material are electrically coupled through a conducting fluid in contact therewith and the voltage potential activates the conductance control module and hence the device. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification